Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Clemmons

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Experimental Diabetes Research|August 7, 2010
Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferationLaura A Maile, Lee B Allen, Christopher F Hanzaker, et al.
Endocrinology|October 1, 2010
Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cellsTeresa Cascella, Yashwanth Radhakrishnan, Laura A Maile, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 2005
Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3Laura A Maile, Walker H Busby, Kevin Sitko, et al.
Arthritis and Rheumatism|March 29, 2002
Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritisDavid R Clemmons, Walker H Busby, Aaron Garmong, et al.
Experimental Diabetes Research|January 30, 2010
Identification of compounds that inhibit IGF-I signaling in hyperglycemiaLaura A Maile, Lee B Allen, Umadevi Veluvolu, et al.
Endocrinology|March 14, 2020
Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null MiceGang Xi, Victoria E Demambro, Susan D'Costa, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?Mark L Hartman, Brenda J Crowe, Beverly M K Biller, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2006
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice GuidelineMark E Molitch, David R Clemmons, Saul Malozowski, et al.
Molecular Endocrinology (Baltimore, Md.)|February 23, 2008
Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-ILaura A Maile, Byron E Capps, Emily C Miller, et al.
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signalingLaura A Maile, Walker H Busby, Kevin Sitko, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Experimental Diabetes Research|August 7, 2010
Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferationLaura A Maile, Lee B Allen, Christopher F Hanzaker, et al.
Endocrinology|October 1, 2010
Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cellsTeresa Cascella, Yashwanth Radhakrishnan, Laura A Maile, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 2005
Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3Laura A Maile, Walker H Busby, Kevin Sitko, et al.
Arthritis and Rheumatism|March 29, 2002
Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritisDavid R Clemmons, Walker H Busby, Aaron Garmong, et al.
Experimental Diabetes Research|January 30, 2010
Identification of compounds that inhibit IGF-I signaling in hyperglycemiaLaura A Maile, Lee B Allen, Umadevi Veluvolu, et al.
Endocrinology|March 14, 2020
Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null MiceGang Xi, Victoria E Demambro, Susan D'Costa, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?Mark L Hartman, Brenda J Crowe, Beverly M K Biller, et al.
The Journal of Clinical Endocrinology and Metabolism|April 26, 2006
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice GuidelineMark E Molitch, David R Clemmons, Saul Malozowski, et al.
Molecular Endocrinology (Baltimore, Md.)|February 23, 2008
Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-ILaura A Maile, Byron E Capps, Emily C Miller, et al.
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signalingLaura A Maile, Walker H Busby, Kevin Sitko, et al.
Pageof 12